Two cell-signaling molecules found to suppress the spread of melanoma

In what is believed to be the largest epigenetic analysis to date of cell-signaling molecules in early-stage melanoma, researchers at NYU Langone Medical Center and its Laura and Isaac Perlmutter Cancer Center have identified two tiny bits of non-coding genetic material in primary tumors that appear critical to stalling the cancer’s spread — and essentially setting the biological fate of the disease. —> Read More Here


Leave a Reply

Your email address will not be published. Required fields are marked *